Literature DB >> 34504019

Activation of Smad2/3 signaling by low fluid shear stress mediates artery inward remodeling.

Hanqiang Deng1, Elizabeth Min1,2, Nicolas Baeyens3,4,5, Brian G Coon1, Rui Hu1, Zhen W Zhuang1,6, Minghao Chen1, Billy Huang1, Titilayo Afolabi1, Georgia Zarkada1, Angela Acheampong5, Kathleen McEntee5, Anne Eichmann1,4,6, Fang Liu7,8,9,10, Bing Su11,12,13, Michael Simons1,2,4, Martin A Schwartz3,2,4,14.   

Abstract

Endothelial cell (EC) sensing of wall fluid shear stress (FSS) from blood flow governs vessel remodeling to maintain FSS at a specific magnitude or set point in healthy vessels. Low FSS triggers inward remodeling to restore normal FSS but the regulatory mechanisms are unknown. In this paper, we describe the signaling network that governs inward artery remodeling. FSS induces Smad2/3 phosphorylation through the type I transforming growth factor (TGF)-β family receptor Alk5 and the transmembrane protein Neuropilin-1, which together increase sensitivity to circulating bone morphogenetic protein (BMP)-9. Smad2/3 nuclear translocation and target gene expression but not phosphorylation are maximal at low FSS and suppressed at physiological high shear. Reducing flow by carotid ligation in rodents increases Smad2/3 nuclear localization, while the resultant inward remodeling is blocked by the EC-specific deletion of Alk5. The flow-activated MEKK3/Klf2 pathway mediates the suppression of Smad2/3 nuclear translocation at high FSS, mainly through the cyclin-dependent kinase (CDK)-2-dependent phosphosphorylation of the Smad linker region. Thus, low FSS activates Smad2/3, while higher FSS blocks nuclear translocation to induce inward artery remodeling, specifically at low FSS. These results are likely relevant to inward remodeling in atherosclerotic vessels, in which Smad2/3 is activated through TGF-β signaling.

Entities:  

Keywords:  KLF2; MEKK3; cyclin-dependent kinase-2; hemodynamics; vascular remodeling

Mesh:

Substances:

Year:  2021        PMID: 34504019      PMCID: PMC8449390          DOI: 10.1073/pnas.2105339118

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  43 in total

1.  The role of ERK5 in endothelial cell function.

Authors:  Gopika N Nithianandarajah-Jones; Bettina Wilm; Christopher E P Goldring; Jürgen Müller; Michael J Cross
Journal:  Biochem Soc Trans       Date:  2014-12       Impact factor: 5.407

Review 2.  Endothelial fluid shear stress sensing in vascular health and disease.

Authors:  Nicolas Baeyens; Chirosree Bandyopadhyay; Brian G Coon; Sanguk Yun; Martin A Schwartz
Journal:  J Clin Invest       Date:  2016-03-01       Impact factor: 14.808

3.  Endothelial-to-mesenchymal transition drives atherosclerosis progression.

Authors:  Pei-Yu Chen; Lingfeng Qin; Nicolas Baeyens; Guangxin Li; Titilayo Afolabi; Madhusudhan Budatha; George Tellides; Martin A Schwartz; Michael Simons
Journal:  J Clin Invest       Date:  2015-10-26       Impact factor: 14.808

4.  HER2/EGFR-AKT Signaling Switches TGFβ from Inhibiting Cell Proliferation to Promoting Cell Migration in Breast Cancer.

Authors:  Fei Huang; Shiwen Luo; Qiaoni Shi; Yuzhen Li; Linlin Xu; Chi Xu; Fenfang Chen; Hai Wang; Hongwei Liao; Zai Chang; Fang Liu; Xiang H-F Zhang; Xin-Hua Feng; Jing-Dong J Han; Ye-Guang Chen
Journal:  Cancer Res       Date:  2018-08-31       Impact factor: 12.701

5.  Tumor necrosis factor alpha-mediated reduction of KLF2 is due to inhibition of MEF2 by NF-kappaB and histone deacetylases.

Authors:  Ajay Kumar; Zhiyong Lin; Sucharita SenBanerjee; Mukesh K Jain
Journal:  Mol Cell Biol       Date:  2005-07       Impact factor: 4.272

Review 6.  TGF-β Signaling from Receptors to Smads.

Authors:  Akiko Hata; Ye-Guang Chen
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-09-01       Impact factor: 10.005

7.  Bone morphogenetic protein-9 is a circulating vascular quiescence factor.

Authors:  Laurent David; Christine Mallet; Michelle Keramidas; Noël Lamandé; Jean-Marie Gasc; Sophie Dupuis-Girod; Henri Plauchu; Jean-Jacques Feige; Sabine Bailly
Journal:  Circ Res       Date:  2008-02-28       Impact factor: 17.367

8.  Identification of N-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1H-pyrazole-3-carboxamide (AT7519), a novel cyclin dependent kinase inhibitor using fragment-based X-ray crystallography and structure based drug design.

Authors:  Paul G Wyatt; Andrew J Woodhead; Valerio Berdini; John A Boulstridge; Maria G Carr; David M Cross; Deborah J Davis; Lindsay A Devine; Theresa R Early; Ruth E Feltell; E Jonathan Lewis; Rachel L McMenamin; Eva F Navarro; Michael A O'Brien; Marc O'Reilly; Matthias Reule; Gordon Saxty; Lisa C A Seavers; Donna-Michelle Smith; Matt S Squires; Gary Trewartha; Margaret T Walker; Alison J-A Woolford
Journal:  J Med Chem       Date:  2008-07-26       Impact factor: 7.446

Review 9.  Preclinical and clinical development of the cyclin-dependent kinase inhibitor flavopiridol.

Authors:  Geoffrey I Shapiro
Journal:  Clin Cancer Res       Date:  2004-06-15       Impact factor: 12.531

10.  Vascular remodeling is governed by a VEGFR3-dependent fluid shear stress set point.

Authors:  Nicolas Baeyens; Stefania Nicoli; Brian G Coon; Tyler D Ross; Koen Van den Dries; Jinah Han; Holly M Lauridsen; Cecile O Mejean; Anne Eichmann; Jean-Leon Thomas; Jay D Humphrey; Martin A Schwartz
Journal:  Elife       Date:  2015-02-02       Impact factor: 8.140

View more
  4 in total

Review 1.  Mechanical regulation of chromatin and transcription.

Authors:  Sirio Dupont; Sara A Wickström
Journal:  Nat Rev Genet       Date:  2022-05-23       Impact factor: 59.581

2.  MEKK3-TGFβ crosstalk regulates inward arterial remodeling.

Authors:  Hanqiang Deng; Yanying Xu; Xiaoyue Hu; Zhen W Zhuang; Yuzhou Chang; Yewei Wang; Aglaia Ntokou; Martin A Schwartz; Bing Su; Michael Simons
Journal:  Proc Natl Acad Sci U S A       Date:  2021-12-21       Impact factor: 12.779

Review 3.  Therapeutic Approaches for Treating Pulmonary Arterial Hypertension by Correcting Imbalanced TGF-β Superfamily Signaling.

Authors:  Patrick Andre; Sachindra R Joshi; Steven D Briscoe; Mark J Alexander; Gang Li; Ravindra Kumar
Journal:  Front Med (Lausanne)       Date:  2022-01-24

Review 4.  Vascular endothelial cell development and diversity.

Authors:  Emily Trimm; Kristy Red-Horse
Journal:  Nat Rev Cardiol       Date:  2022-10-05       Impact factor: 49.421

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.